vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.

Community Healthcare Trust Inc is the larger business by last-quarter revenue ($31.5M vs $17.2M, roughly 1.8× Invivyd, Inc.). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs -64.3%, a 72.4% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 4.8%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.

CHCT vs IVVD — Head-to-Head

Bigger by revenue
CHCT
CHCT
1.8× larger
CHCT
$31.5M
$17.2M
IVVD
Growing faster (revenue YoY)
IVVD
IVVD
+19.7% gap
IVVD
24.5%
4.8%
CHCT
Higher net margin
CHCT
CHCT
72.4% more per $
CHCT
8.1%
-64.3%
IVVD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CHCT
CHCT
IVVD
IVVD
Revenue
$31.5M
$17.2M
Net Profit
$2.5M
$-11.1M
Gross Margin
Operating Margin
-73.0%
Net Margin
8.1%
-64.3%
Revenue YoY
4.8%
24.5%
Net Profit YoY
60.2%
40.0%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
IVVD
IVVD
Q1 26
$31.5M
Q4 25
$30.9M
$17.2M
Q3 25
$31.1M
$13.1M
Q2 25
$29.1M
$11.8M
Q1 25
$30.1M
$11.3M
Q4 24
$29.3M
$13.8M
Q3 24
$29.6M
$9.3M
Q2 24
$27.5M
$2.3M
Net Profit
CHCT
CHCT
IVVD
IVVD
Q1 26
$2.5M
Q4 25
$14.4M
$-11.1M
Q3 25
$1.6M
$-10.5M
Q2 25
$-12.6M
$-14.7M
Q1 25
$1.6M
$-16.3M
Q4 24
$1.8M
$-18.4M
Q3 24
$1.7M
$-60.7M
Q2 24
$-10.4M
$-47.2M
Operating Margin
CHCT
CHCT
IVVD
IVVD
Q1 26
Q4 25
-73.0%
Q3 25
-84.0%
Q2 25
-127.8%
Q1 25
-149.7%
Q4 24
-139.1%
Q3 24
-670.0%
Q2 24
-2175.2%
Net Margin
CHCT
CHCT
IVVD
IVVD
Q1 26
8.1%
Q4 25
46.6%
-64.3%
Q3 25
5.3%
-79.7%
Q2 25
-43.2%
-124.4%
Q1 25
5.3%
-144.1%
Q4 24
6.3%
-133.5%
Q3 24
5.9%
-653.1%
Q2 24
-37.9%
-2086.9%
EPS (diluted)
CHCT
CHCT
IVVD
IVVD
Q1 26
Q4 25
$0.52
$0.02
Q3 25
$0.03
$-0.06
Q2 25
$-0.50
$-0.12
Q1 25
$0.03
$-0.14
Q4 24
$0.04
$-0.14
Q3 24
$0.04
$-0.51
Q2 24
$-0.42
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
IVVD
IVVD
Cash + ST InvestmentsLiquidity on hand
$2.6M
$226.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$421.3M
$241.5M
Total Assets
$1.0B
$276.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
IVVD
IVVD
Q1 26
$2.6M
Q4 25
$3.3M
$226.7M
Q3 25
$3.4M
$85.0M
Q2 25
$4.9M
$34.9M
Q1 25
$2.3M
$48.1M
Q4 24
$4.4M
$69.3M
Q3 24
$2.8M
$106.9M
Q2 24
$734.0K
$147.9M
Total Debt
CHCT
CHCT
IVVD
IVVD
Q1 26
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Stockholders' Equity
CHCT
CHCT
IVVD
IVVD
Q1 26
$421.3M
Q4 25
$429.4M
$241.5M
Q3 25
$426.8M
$93.1M
Q2 25
$437.8M
$42.8M
Q1 25
$461.3M
$54.1M
Q4 24
$476.0M
$67.5M
Q3 24
$477.2M
$83.2M
Q2 24
$497.8M
$140.6M
Total Assets
CHCT
CHCT
IVVD
IVVD
Q1 26
$1.0B
Q4 25
$990.8M
$276.9M
Q3 25
$987.3M
$139.2M
Q2 25
$966.3M
$89.1M
Q1 25
$985.1M
$103.7M
Q4 24
$992.6M
$129.5M
Q3 24
$981.8M
$161.9M
Q2 24
$983.2M
$177.3M
Debt / Equity
CHCT
CHCT
IVVD
IVVD
Q1 26
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
IVVD
IVVD
Operating Cash FlowLast quarter
$-15.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
IVVD
IVVD
Q1 26
Q4 25
$56.4M
$-15.5M
Q3 25
$12.7M
$-8.3M
Q2 25
$13.8M
$-13.3M
Q1 25
$14.4M
$-21.1M
Q4 24
$58.9M
$-37.6M
Q3 24
$13.8M
$-41.1M
Q2 24
$16.7M
$-41.6M
Free Cash Flow
CHCT
CHCT
IVVD
IVVD
Q1 26
Q4 25
$35.9M
Q3 25
$7.6M
Q2 25
$9.6M
$-13.3M
Q1 25
$9.7M
$-21.3M
Q4 24
$34.2M
$-37.6M
Q3 24
$6.7M
$-41.1M
Q2 24
$9.5M
FCF Margin
CHCT
CHCT
IVVD
IVVD
Q1 26
Q4 25
116.0%
Q3 25
24.6%
Q2 25
32.9%
-112.9%
Q1 25
32.3%
-188.2%
Q4 24
116.9%
-272.2%
Q3 24
22.5%
-441.6%
Q2 24
34.7%
Capex Intensity
CHCT
CHCT
IVVD
IVVD
Q1 26
Q4 25
66.3%
0.0%
Q3 25
16.3%
0.0%
Q2 25
14.5%
0.1%
Q1 25
15.6%
1.3%
Q4 24
84.1%
0.0%
Q3 24
24.2%
0.1%
Q2 24
26.1%
0.0%
Cash Conversion
CHCT
CHCT
IVVD
IVVD
Q1 26
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons